Skip to main content

Health: diagnose conditions and pathologies

The first insulin resistance diagnosis urine test

Rapid urine test to screen for insulin resistance

Health: diagnose conditions and pathologies

The first insulin resistance diagnosis urine test

Rapid urine test to screen for insulin resistance

Key health information to combat a slow-motion disaster

SkillCell has developed IDIR®, the first urine test to diagnose insulin resistance. With this first CE-marked test, SkillCell addresses the issue of metabolic diseases using an efficient, easy-to-use and cost-effective diagnosis and prevention tool.

Insulin resistance is a condition in which cells have a reduced capacity to respond to the insulin hormone. Insulin resistance is highly correlated to unhealthy dietary habits, sedentary life-styles and obesity. It is often an early condition that leads to chronic diseases such as type 2 diabetes or NASH (non-alcoholic steatohepatitis) and their related complications. Insulin resistance is also a condition that can be reversed in a few months. Its diagnosis is therefore a powerful prevention tool for the chronic metabolic diseases mentioned above.

A dramatic global increase in metabolic disorders

Economic growth and modernization have led to lifestyle-related chronic diseases. Unhealthy dietary habits and the movement from active to sedentary lifestyles are dramatically increasing obesity and insulin resistance in the population, leading to diseases such as T2 diabetes or NASH. The onset of these pathologies is usually slow and difficult to determine, but their complications are extremely harmful and can absorb up to 20% of the entire healthcare budget of several countries, making it one of the biggest global health crises of the 21st century.

 

If current trends continue, almost a quarter (22%) of the people in the world will be obese by 2045 (up from 14% in 2017), and one in eight (12%) will have type 2 diabetes (up from 9% in 2017).

 

NASH prevalence could increase of 63% from 2015 to 2030 (Estes, 2018). In the US, we estimate that NASH will become the main cause of liver transplant by 2020.

Prevent as early as possible

IDIR’s mission is to provide people with transparent and critical health information to help them manage their health and avoid the transition from insulin resistance to chronic metabolic diseases, while at the same time encouraging obesity management measures.

Several large-scale randomized controlled trials carried out in different countries confirm that prevention is efficient and cost effective to prevent chronic metabolic diseases such as type 2 diabetes. Prevention actions include early diagnosis followed by lifestyle interventions, insulin and blood-glucose lowering drug treatments, etc. As an easy-to-use and cost-effective test, IDIR is an ideal solution for such prevention actions.

  • Easy & Fast:
    • No lab required: at home, in the morning, after a fasting period
    • Results in 15 minutes; color change
  • Reliable & Efficient: sensitive and specific, CE-marked
  • Cost-effective: low price; replaces a fully-equipped lab
  • Safe and biodegradable: only proteins inside

IDIR®: Screening campaigns – Prescription – Auto-test

  • Detect people at risk as early as possible
  • Raise awareness about the importance of reversing insulin resistance
  • Encourage everyone to implement effective existing solutions
  • Support public health systems by lowering the huge financial burden it represents
Legal Notice | © ALCEN — All rights reserved